Literature DB >> 7928088

Activity of two synthetic amphiphilic peptides and magainin-2 against herpes simplex virus types 1 and 2.

Y Aboudy1, E Mendelson, I Shalit, R Bessalle, M Fridkin.   

Abstract

The in vitro antiviral activity of two amphiphilic synthetic peptides, modelin-1 (mod-1) and modelin-5 (mod-5), and of the natural antibacterial peptide magainin-2 (mag-2) against herpes simplex viruses type 1 (HSV-1) and 2 (HSV-2) were evaluated. The peptides were incubated with the virus, i.e. direct inactivation, and their effects examined by means of plaque reduction assay and/or reduction in virus yield. Only mod-1 displayed a strong antiviral effect against HSV-1 and HSV-2, with 50% effective dose (ED50) values of 4.6 and 4.1 micrograms/mL, respectively. Mag-2, mod-5 and a mixture of both had no significant inhibitory effect. Addition of mod-1 up to a concentration of 100 micrograms/mL to the culture medium had no significant cytotoxic effect on host vero cells, as measured by the trypan blue-exclusion method. It showed, however, considerable hemolytic activity against human red blood cells. Experiments including acyclovir (ACV) as a reference viral inhibitor indicated that the mode of action of mod-1 is different from that of ACV. In contrast to ACV, the peptide inactivates the virus following a very short incubation before vero cell infection, suggesting some kind of direct interaction of the peptide with the viral envelope, rather than inhibition of viral DNA replication or gene expression. Our results suggest that mod-1 may be an effective topical antiviral agent against herpes viruses.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7928088     DOI: 10.1111/j.1399-3011.1994.tb00559.x

Source DB:  PubMed          Journal:  Int J Pept Protein Res        ISSN: 0367-8377


  15 in total

Review 1.  Nonmammalian vertebrate antibiotic peptides.

Authors:  P Síma; I Trebichavský; K Sigler
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

Review 2.  Peptide antimicrobial agents.

Authors:  Håvard Jenssen; Pamela Hamill; Robert E W Hancock
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

3.  Inhibition of a plant virus infection by analogs of melittin.

Authors:  J F Marcos; R N Beachy; R A Houghten; S E Blondelle; E Pérez-Payá
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

4.  Characterization of novel antimicrobial peptoids.

Authors:  B Goodson; A Ehrhardt; S Ng; J Nuss; K Johnson; M Giedlin; R Yamamoto; W H Moos; A Krebber; M Ladner; M B Giacona; C Vitt; J Winter
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

5.  Structure and dynamics of the antibiotic peptide PGLa in membranes by solution and solid-state nuclear magnetic resonance spectroscopy.

Authors:  B Bechinger; M Zasloff; S J Opella
Journal:  Biophys J       Date:  1998-02       Impact factor: 4.033

6.  iTRAQ-coupled 2-D LC-MS/MS analysis of membrane protein profile in Escherichia coli incubated with apidaecin IB.

Authors:  Yusi Zhou; Wei Ning Chen
Journal:  PLoS One       Date:  2011-06-01       Impact factor: 3.240

7.  Therapeutic approaches using host defence peptides to tackle herpes virus infections.

Authors:  Håvard Jenssen
Journal:  Viruses       Date:  2009-11-18       Impact factor: 5.048

8.  Identification of the Active Principle Conferring Anti-Inflammatory and Antinociceptive Properties in Bamboo Plant.

Authors:  Bruna Araujo Sousa; Osmar Nascimento Silva; William Farias Porto; Thales Lima Rocha; Luciano Paulino Silva; Ana Paula Ferreira Leal; Danieli Fernanda Buccini; James Oluwagbamigbe Fajemiroye; Ruy de Araujo Caldas; Octávio Luiz Franco; Maria Fátima Grossi-de-Sá; Cesar de la Fuente Nunez; Susana Elisa Moreno
Journal:  Molecules       Date:  2021-05-20       Impact factor: 4.411

9.  A cancer specific cell-penetrating peptide, BR2, for the efficient delivery of an scFv into cancer cells.

Authors:  Ki Jung Lim; Bong Hyun Sung; Ju Ri Shin; Young Woong Lee; Da Jung Kim; Kyung Seok Yang; Sun Chang Kim
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

Review 10.  Current scenario of peptide-based drugs: the key roles of cationic antitumor and antiviral peptides.

Authors:  Kelly C L Mulder; Loiane A Lima; Vivian J Miranda; Simoni C Dias; Octávio L Franco
Journal:  Front Microbiol       Date:  2013-10-31       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.